Fulgent Genetics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $76,214 | $71,743 | $71,028 | $64,485 |
Gross Profit | 31,849 | 26,771 | 24,501 | 20,114 |
EBITDA | -9,943 | -12,598 | -12,753 | -15,135 |
EBIT | -16,135 | -18,518 | -18,906 | -21,798 |
Net Income | -5,888 | -14,648 | -8,710 | -13,462 |
Net Change In Cash | 76,214 | 71,743 | 71,028 | 64,485 |
Free Cash Flow | 21,240 | -35,046 | -8,659 | 3,210 |
Cash | 55,144 | 58,042 | 65,111 | 54,677 |
Basic Shares | 30,652 | 30,416 | 30,098 | 29,769 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $283,470 | $289,213 | $618,968 | $992,584 |
Gross Profit | 107,215 | 104,456 | 366,901 | 777,051 |
EBITDA | -73,918 | -46,552 | 221,585 | 106,047 |
EBIT | -72,695 | 184,675 | 104,339 | |
Net Income | -42,708 | -167,825 | 143,403 | 104,339 |
Net Change In Cash | 283,470 | 289,213 | 618,968 | 992,584 |
Cost of Revenue | 77,434 | |||
Free Cash Flow | -19,255 | 4,796 | 234,745 | 514,733 |
Cash | 55,144 | 97,473 | 79,506 | 164,894 |
Basic Shares | 30,235 | 29,784 | 30,964 | 30,976 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.04 |
2024-09-30 | $0.31 |
2024-06-30 | $0.15 |
2024-03-31 | -$0.01 |
